4728 Stock Overview
A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Sunmax Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$274.00 |
| 52 Week High | NT$350.00 |
| 52 Week Low | NT$191.50 |
| Beta | 0.32 |
| 1 Month Change | -0.54% |
| 3 Month Change | 4.18% |
| 1 Year Change | 37.00% |
| 3 Year Change | 234.15% |
| 5 Year Change | 246.40% |
| Change since IPO | 576.21% |
Recent News & Updates
Recent updates
Investors Who Bought Sunmax Biotechnology (GTSM:4728) Shares Three Years Ago Are Now Up 166%
Feb 28
Is Sunmax Biotechnology Co., Ltd. (GTSM:4728) The Right Choice For A Smart Dividend Investor?
Feb 02Sunmax Biotechnology Co., Ltd.'s (GTSM:4728) Stock Is Going Strong: Is the Market Following Fundamentals?
Dec 20Is Sunmax Biotechnology's (GTSM:4728) Share Price Gain Of 152% Well Earned?
Nov 24
Shareholder Returns
| 4728 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | -0.5% | -2.6% | -2.1% |
| 1Y | 37.0% | -0.8% | 25.6% |
Return vs Industry: 4728 exceeded the TW Biotechs industry which returned -0.8% over the past year.
Return vs Market: 4728 exceeded the TW Market which returned 25.6% over the past year.
Price Volatility
| 4728 volatility | |
|---|---|
| 4728 Average Weekly Movement | 2.8% |
| Biotechs Industry Average Movement | 4.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4728 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4728's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Ming Yi Lin | www.sunmaxbiotech.com |
Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax FACIALGAIN collagen implant with lidocaine, Sunmax collagen implant I-Plus, Sumax collagen implant I, Sunmax FACIALGAIN collagen implant 1-Plus with lidocaine for the correction of facial defects, such as the fill up of wrinkles; and Porcogen, a sterile purified collagen solution for medical device, tissue engineering, and research purposes. It also provides Sunmax collagen dental bone graft, Sunmax collagen dental membrane, and Sunmax dental bone graft granules, which are used in the augmentation or reconstructive treatment of the alveolar ridge.
Sunmax Biotechnology Co., Ltd. Fundamentals Summary
| 4728 fundamental statistics | |
|---|---|
| Market cap | NT$14.92b |
| Earnings (TTM) | NT$698.95m |
| Revenue (TTM) | NT$1.74b |
21.4x
P/E Ratio8.6x
P/S RatioIs 4728 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4728 income statement (TTM) | |
|---|---|
| Revenue | NT$1.74b |
| Cost of Revenue | NT$314.37m |
| Gross Profit | NT$1.43b |
| Other Expenses | NT$730.04m |
| Earnings | NT$698.95m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.83 |
| Gross Margin | 81.97% |
| Net Profit Margin | 40.09% |
| Debt/Equity Ratio | 0% |
How did 4728 perform over the long term?
See historical performance and comparisonDividends
4.0%
Current Dividend Yield86%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 21:18 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sunmax Biotechnology Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Regina Lee | Jih Sun Securities Investment Consulting Co., Ltd. |